As initiation of inflammation and its sustained level is a major contributor of ovarian tumorigenesis [82, 83], it can be postulated that the differences in the ratios of TIMP-2 and MMPs may be a tipping point in controlling the tumorigenic behaviour of ovarian cancer cells. The gene discussed is TIMP2; the disease is ovarian cancer.